Physician profile
Ryan S Charette
NPI 1396130639
$16,348.14
in general payments reported to CMS, 2019-2025
14 companies · $9.96 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $980 · 2020: $5,716 · 2021: $8,354 · 2022: $541 · 2023: $293 · 2024: $454 · 2025: $9.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $757.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $13,044.76 | 2019-2023 | Real Intelligence, Journey II |
| Stryker Corporation | $1,402.23 | 2019-2024 | Mako, Gamma |
| Depuy Synthes Sales INC. | $755.43 | 2019-2024 | Actis |
| Zimmer Biomet Holdings, INC. | $329.53 | 2019-2021 | |
| Linkbio Corp | $285.51 | 2021 | |
| Davol INC. | $158.61 | 2022 | |
| Medical Device Business Services, INC. | $123.48 | 2022 | |
| Janssen Pharmaceuticals, INC | $118.06 | 2019 | |
| Bioventus LLC | $29.78 | 2022 | |
| Ermi LLC | $27.38 | 2019 | |
| Zimvie INC. | $24.27 | 2023 | |
| Convatec INC. | $21.90 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.24 | 2022 | |
| Orthofix Medical, INC. | $9.96 | 2025 | Spinal-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Charette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.